Curtiss-Wright Investing Cash Flow increased by 68.7% to -$11.52M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 53.7%, from -$24.89M to -$11.52M. Over 4 years (FY 2021 to FY 2025), Investing Cash Flow shows a downward trend with a 20.7% CAGR.
A negative value typically signals investment in future growth, while a positive value may indicate divestment or the maturity of a large investment portfolio.
This metric is the net total of all cash inflows and outflows related to investing activities, including capital expendi...
Most mature healthcare companies maintain a negative net investing cash flow due to ongoing R&D and infrastructure investment.
net_cash_from_investing| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$7.27M | -$9.68M | -$12.59M | -$10.39M | -$7.84M | -$263.72M | -$43.91M | -$10.44M | -$11.75M | -$9.38M | -$3.95M | -$12.01M | -$44.73M | -$13.51M | -$213.06M | -$24.89M | -$11.66M | -$16.78M | -$36.79M | -$11.52M |
| QoQ Change | — | -33.1% | -30.1% | +17.5% | +24.5% | <-999% | +83.3% | +76.2% | -12.6% | +20.2% | +57.9% | -204.5% | -272.3% | +69.8% | <-999% | +88.3% | +53.2% | -43.9% | -119.3% | +68.7% |
| YoY Change | — | — | — | — | -7.8% | <-999% | -248.7% | -0.4% | -49.8% | +96.4% | +91.0% | -15.1% | -280.5% | -44.0% | <-999% | -107.2% | +73.9% | -24.2% | +82.7% | +53.7% |